Pd-Rx Pharmaceutical Correlations

PDRX Stock  USD 2.90  0.00  0.00%   
The correlation of Pd-Rx Pharmaceutical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Pd-Rx Pharmaceutical Correlation With Market

Good diversification

The correlation between Pd Rx Pharmaceutical and DJI is -0.12 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Pd Rx Pharmaceutical and DJI in the same portfolio, assuming nothing else is changed.
  
The ability to find closely correlated positions to Pd-Rx Pharmaceutical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Pd-Rx Pharmaceutical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Pd-Rx Pharmaceutical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Pd Rx Pharmaceutical to buy it.

Moving against Pd-Rx Pink Sheet

  0.46STAG STAG IndustrialPairCorr
  0.45PBCRY Bank Central AsiaPairCorr
  0.42PBCRF PT Bank CentralPairCorr
  0.39SHIP Seanergy MaritimePairCorr
  0.37BKRKF PT Bank RakyatPairCorr
  0.34SHG Shinhan FinancialPairCorr
  0.33KB KB Financial GroupPairCorr
  0.3268233JBP8 US68233JBP84PairCorr
  0.31SMGKF Smiths Group plcPairCorr
  0.48CHACR Crane Harbor AcquisitionPairCorr
  0.41EFTR Effector TherapeuticsPairCorr
  0.32DNLMY Dunelm Group PLCPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

RPNRFRNVA
SRNEKOSK
SRNERMSL
FZMDKOSK
RMSLFZMD
RMSLKOSK
  

High negative correlations

IDXGRMSL
MVMDFKOSK
CPIVFKOSK
IDXGSRNE
MVMDFIDXG
MVMDFFZMD

Risk-Adjusted Indicators

There is a big difference between Pd-Rx Pink Sheet performing well and Pd-Rx Pharmaceutical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Pd-Rx Pharmaceutical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
KOSK  8.98  0.41  0.02  1.86  12.94 
 22.22 
 70.33 
FZMD  8.98  0.83  0.00  0.22  0.00 
 0.00 
 321.43 
RMSL  6.48 (0.44) 0.00  0.84  0.00 
 20.00 
 64.13 
SEHCF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
SRNE  15.63  1.21  0.07  0.19  17.67 
 39.53 
 151.48 
RNVA  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
CPIVF  26.82  7.61  0.19 (2.10) 21.58 
 125.98 
 214.91 
IDXG  5.10  0.76  0.11  1.04  5.55 
 14.29 
 43.31 
RPNRF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
MVMDF  7.54  0.99  0.05 (0.61) 9.52 
 27.00 
 68.80 

Be your own money manager

Our tools can tell you how much better you can do entering a position in Pd-Rx Pharmaceutical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Cryptocurrency Center Now

   

Cryptocurrency Center

Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
All  Next Launch Module

Pd-Rx Pharmaceutical Corporate Management

RPh DOCEO ChairmanProfile
Jack IIExec COOProfile
Robert BakerTreasurer CFOProfile
Robert SurovecRegulatory OfficerProfile